Replies to post #240127 on Biotech Values

[DewDiligence]

MYOV—CHMP approves Orgovyx for HSPC:

https://www.globenewswire.com/news-release/2022/02/25/2392377/0/en/Myovant-Sciences-Receives-Positive-CHMP-Opinion-for-ORGOVYX-relugolix-for-the-Treatment-of-Advanced-Prostate-Cancer.html

MYOV is still seeking a partner for the European rights to Orgovyx. The PR says MYOV expects to have a deal in the next two months or so.